West Pharmaceutical Services (WST) Non Operating Income (2011 - 2026)
West Pharmaceutical Services (WST) posted Non Operating Income of -$12.8 million for Q2 2026, down 220.0% sequentially from -$4.0 million in Q1 2026, and down 146.15% YoY from $27.7 million in Q2 2025.
West Pharmaceutical Services (WST) Non Operating Income (2011 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Non Operating Income for 16 years, with the latest figure at -$12.8 million in Q2 2026.
- Quarterly Non Operating Income fell 146.15% year-over-year to -$12.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$42.2 million (down 4.46% YoY) and the FY2025 annual result came in at -$51.2 million, down 143.81% from the prior year.
- Non Operating Income retreated to -$12.8 million in Q2 2026 per WST's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $26.3 million in Q4 2022 and troughed at -$50.0 million in Q3 2022.
- A 5-year average of -$6.8 million and a median of -$4.8 million in 2024 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 636.73% in 2022, down 2677.78% in 2022.
- Over 5 years, Non Operating Income stood at $26.3 million in 2022, then slumped by 133.84% to -$8.9 million in 2023, then fell by 14.61% to -$10.2 million in 2024, then sank by 81.37% to -$18.5 million in 2025, then soared by 30.81% to -$12.8 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$12.8 million, -$4.0 million, and -$18.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -9.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.80 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | -18.50 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -5.20 Mn |
| Mar 31, 2025 | -20.60 Mn |
| Dec 31, 2024 | -10.20 Mn |
| Sep 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | -3.30 Mn |
| Mar 31, 2024 | -3.10 Mn |
| Dec 31, 2023 | -8.90 Mn |
| Sep 30, 2023 | 9.70 Mn |
| Jun 30, 2023 | -4.00 Mn |
| Mar 31, 2023 | -12.90 Mn |
| Dec 31, 2022 | 26.30 Mn |
| Sep 30, 2022 | -50.00 Mn |
| Jun 30, 2022 | 2.80 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | -4.90 Mn |
| Sep 30, 2021 | -1.80 Mn |